| JAMFX | JATNX | JAMFX / JATNX | |
| Total Expense Ratio | 2.38 | 0.69 | 345% |
| Annual Report Gross Expense Ratio | 2.38 | 0.69 | 345% |
| Fund Existence | 27 years | 10 years | - |
| Gain YTD | -10.567 | 26.107 | -40% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 42.9M | 10.4B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -22.03 | 17.72 | -124% |
| Returns for 3 years | 35.50 | 79.78 | 44% |
| Returns for 5 years | -47.90 | 33.32 | -144% |
| Returns for 10 years | 28.92 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FCGEX | 21.69 | 0.02 | +0.09% |
| NYLIM PineStone Global Equity Class A | |||
| FBTCX | 38.09 | N/A | N/A |
| Fidelity Advisor Biotechnology C | |||
| FICHX | 17.20 | N/A | N/A |
| Cantor Fitzgerald Large Cap Fcs Cl Inst | |||
| JATSX | 77.76 | N/A | N/A |
| Janus Henderson Glb Tech and Innovt S | |||
| FSBCX | 23.09 | -0.02 | -0.09% |
| Federated Hermes Global Allocation C | |||